clinical trials

By Dave Muoio January 23, 2018
Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners. The new funding will be used to accelerate product development, improve customer service capacities, and boost sales and marketing efforts, according to the company. “Our business is founded on...
By Jonah Comstock December 27, 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health,...
By Dave Muoio December 1, 2017
Editor's note: Since publication, some of this story's quotes have been edited for clarity. With billions of dollars and countless hours of human effort spent each year validating new drugs, devices, and medical interventions, it’s little surprise that the healthcare industry is turning to technology to streamline the process. From participant recruitment to data collection to adherence, clinical...
By Jonah Comstock October 11, 2017
Janssen Research and Development, a Johnson & Johnson subsidiary, will launch the first clinical trial to use its iSTEP technology toolset, which employs smart blisterpacks and a patient-facing smartphone app, by the end of the year. iSTEP, which stands for Integrated Smart Trial and Engagement Platform, has been under development at Janssen for five years. “The mission of Janssen as an...
By Jonah Comstock September 15, 2017
One of the biggest promises of mobile health apps and wearables is the sheer amount of data they collect. As that dataset grows, a number of different stakeholders are taking an interest in it, among them patients themselves, doctors, and clinical researchers. The latter is the focus of a new report out today from the Duke-Margolis Center for Health Policy. “Under a collaborative agreement with...
By Bill Siwicki September 7, 2017
VitalTrax has launched Wing, its clinical trials electronic network that gives patients, caregivers and physicians a streamlined experience for finding and enrolling in clinical trials. Wing, which can be accessed at PatientWing.com, also offers clinical trials sponsors and provider research sites the ability to publish and promote their trials for increased visibility. Research sites are...
By Heather Mack July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use. For $99,...
By Jonah Comstock June 26, 2017
The Clinical Trials Transformation Initiative (CTTI), a public-private partnership of pharma companies, academics, and regulators, including FDA, looking to create a new “gold standard” of clinical trial design using digital technology, released new endpoint recommendations today focused on the use of mobile technology in clinical trials.  “By engaging with experts who have been early champions...
By Jonah Comstock May 5, 2017
Crystal Lake, Illinois-based Aptar Pharma is teaming up with digital health startup Kali Care to develop a new way of measuring adherence to eye drops in clinical trials.  Because they are somewhat onerous to use, eye drops have even lower rates of adherence than other medications. Kali Care, based in Silicon Valley, makes a small sensor that can be installed in a container for eye drop...
By Jonah Comstock April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...

Editor's Pick

www.steroid-pharm.com

also read

Баден Баден лечение